The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C

The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C

Introduction. Viral hepatitis C (HCV) is a significant global health problem. The risk of developing chronic HCV is up to 80% of patients, of whom 10-20% can develop liver cirrhosis or hepatocellular carcinoma which can lead to death. Treatment with direct-acting antiviral agents (DAAs) contributes...

Full description

Bibliographic Details
Main Authors: Irina RUSU, Liliana HODOROGEA, Tiberiu HOLBAN
Format: Article
Language:English
Published: Asociatia de Biosiguranta si Biosecuritate 2020-03-01
Series:One Health & Risk Management
Subjects:
chronic hcv
treatment
sofosbuvir
ledipasvir
daclatasvir
Online Access:https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/25/11

Similar Items

Similar Items